2(5H)-Furanone, 5-hydroxy-4-methyl- → ethyl [4-methyl-6-oxopyridazin-1(6H)-yl]acetate

HRID 243678

Reaktionsgleichung

Reaktionsgleichung von HRID 243678
O[CH:2]1[O:6][C:5](=O)[CH:4]=[C:3]1[CH3:8].Cl.[NH:10]([CH2:12][C:13]([O:15][CH2:16][CH3:17])=[O:14])[NH2:11]>C(O)C>[CH3:2][C:3]1[CH:8]=[N:11][N:10]([CH2:12][C:13]([O:15][CH2:16][CH3:17])=[O:14])[C:5](=[O:6])[CH:4]=1

Komponenten

4

Versuchsvorschrift

5-Hydroxy-4-methylfuran-2(5H)-one (1.19 g, 10.4 mmol) and ethyl hydrazinoacetate hydrochloride (1.61 g, 10.4 mmol) in 95% ethanol (20 mL) was refluxed for 2 h. Removal of the solvent in vacuo followed by purification using a Biotage Horizon® system (0-50% ethyl acetate/hexanes mixture) gave ethyl [4-methyl-6-oxopyridazin-1(6H)-yl]acetate as a yellow crystalline. LC/MS 219.2 (M+23).

Aufarbeitung

  1. customRemoval of the solvent in vacuo
  2. customfollowed by purification

Quellen und Nachweise

ORD-Eintrag
ord-3219945a94c34963a373004fac3c590c
Quelldatensatz
uspto-grants-2014_02
Patentnummer
US08653260B2

Verknüpfte Notizen

Wird geladen…